A
KURA icon

AlphaQuest’s Kura Oncology KURA Stock Holding History

AlphaQuest’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-42,185
Closed -$438K – 1088
2025
Q4 		$438K Buy
42,185
+14,041
+50% +$147K 0.02% 922
2025
Q3 		$249K Sell
28,144
-1,073
-4% -$7.65K 0.02% 1277
2025
Q2 		$169K Sell
29,217
-29,555
-50% -$181K 0.02% 1226
2025
Q1 		$388K Buy
58,772
+38,441
+189% +$300K 0.04% 643
2024
Q4 		$177K Buy
+20,331
New +$293K 0.02% 907
2024
Q1 		– Sell
-343
Closed -$4.93K – 1726
2023
Q4 		$4.93K Buy
+343
New +$3.37K ﹤0.01% 1008

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AlphaQuest's KURA Position: Q1 2026 in Review

AlphaQuest sold out of Kura Oncology (KURA) in Q1 2026, closing a stake of 42,185 shares — an estimated $438K sold.

AlphaQuest first reported a position in KURA in Q4 2023 and held it in 6 quarters. The position peaked at $438K in Q4 2025. 222 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • AlphaQuest reported no remaining Kura Oncology position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 42,185 Kura Oncology shares in Q1 2026, an estimated $438K.
  • AlphaQuest first reported a position in Kura Oncology in Q4 2023 and held it in 6 quarters.
  • AlphaQuest's Kura Oncology position peaked at $438K in Q4 2025.
  • 222 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.